Hepatitis C Virus Reinfection Among Men Who Have Sex With Men With HIV in New York City.

IF 8.2 1区 医学 Q1 IMMUNOLOGY
Daniel S Fierer, Jesse R Carollo, Gabriela Rodriguez-Caprio, Asa Radix, Rona Vail, Robert Chavez, Krisczar J Bungay, Stephen M Dillon
{"title":"Hepatitis C Virus Reinfection Among Men Who Have Sex With Men With HIV in New York City.","authors":"Daniel S Fierer, Jesse R Carollo, Gabriela Rodriguez-Caprio, Asa Radix, Rona Vail, Robert Chavez, Krisczar J Bungay, Stephen M Dillon","doi":"10.1093/cid/ciae297","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hepatitis C virus (HCV) reinfection rates are substantially higher than primary infection rates among men who have sex with men (MSM) with human immunodeficiency virus (HIV) in European cohorts. The behaviors mediating this high rate of transmission among MSM are poorly characterized.</p><p><strong>Methods: </strong>We performed a prospective cohort study in New York City (NYC) of MSM with HIV who cleared HCV to determine the incidence of and risk factors for HCV reinfection. We assessed the risk behaviors for primary HCV in NYC: receipt of semen in the rectum, and sexualized methamphetamine use, along with route of use. Multivariable analysis was performed with Andersen-Gill extension of the Cox proportional hazards model.</p><p><strong>Results: </strong>From 2000 through 2018, among 304 MSM with HIV who cleared HCV, 42 reinfections occurred over 898 person-years, for an incidence rate of 4.7 per 100 person-years. Assessing 1245 postclearance visits, only receipt of semen into the rectum was associated with reinfection (hazard ratio, 9.7 [95% confidence interval: 3.3-28.3], P < .001); methamphetamine use was not.</p><p><strong>Conclusions: </strong>The high HCV reinfection rate over almost 2 decades demonstrates that sexual transmission of HCV is not inefficient or unusual and that direct-acting antiviral treatment is not sufficient for HCV elimination among MSM in NYC. The contrasts between both the rates of and risk factors for primary and HCV reinfection suggest that HCV prevalence is highly heterogenous among sexual networks and that sexualized methamphetamine use, rather than mediating transmission, is instead a surrogate marker for the highest HCV prevalence networks. As neither condoms nor treatment have been successful strategies for HCV prevention in NYC, novel interventions are needed to stem this sexually transmitted HCV epidemic.</p>","PeriodicalId":10463,"journal":{"name":"Clinical Infectious Diseases","volume":" ","pages":"1420-1427"},"PeriodicalIF":8.2000,"publicationDate":"2024-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/cid/ciae297","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Hepatitis C virus (HCV) reinfection rates are substantially higher than primary infection rates among men who have sex with men (MSM) with human immunodeficiency virus (HIV) in European cohorts. The behaviors mediating this high rate of transmission among MSM are poorly characterized.

Methods: We performed a prospective cohort study in New York City (NYC) of MSM with HIV who cleared HCV to determine the incidence of and risk factors for HCV reinfection. We assessed the risk behaviors for primary HCV in NYC: receipt of semen in the rectum, and sexualized methamphetamine use, along with route of use. Multivariable analysis was performed with Andersen-Gill extension of the Cox proportional hazards model.

Results: From 2000 through 2018, among 304 MSM with HIV who cleared HCV, 42 reinfections occurred over 898 person-years, for an incidence rate of 4.7 per 100 person-years. Assessing 1245 postclearance visits, only receipt of semen into the rectum was associated with reinfection (hazard ratio, 9.7 [95% confidence interval: 3.3-28.3], P < .001); methamphetamine use was not.

Conclusions: The high HCV reinfection rate over almost 2 decades demonstrates that sexual transmission of HCV is not inefficient or unusual and that direct-acting antiviral treatment is not sufficient for HCV elimination among MSM in NYC. The contrasts between both the rates of and risk factors for primary and HCV reinfection suggest that HCV prevalence is highly heterogenous among sexual networks and that sexualized methamphetamine use, rather than mediating transmission, is instead a surrogate marker for the highest HCV prevalence networks. As neither condoms nor treatment have been successful strategies for HCV prevention in NYC, novel interventions are needed to stem this sexually transmitted HCV epidemic.

纽约市感染艾滋病毒的男男性行为者中的丙型肝炎病毒再感染。
背景:在欧洲队列中,丙型肝炎病毒(HCV)再感染率远远高于感染人类免疫缺陷病毒(HIV)的男男性行为者(MSM)的初次感染率。导致男男性行为者中这一高传播率的行为特征尚不明确:我们在纽约市(NYC)开展了一项前瞻性队列研究,研究对象是已清除 HCV 的 HIV MSM,以确定 HCV 再感染的发生率和风险因素。我们评估了纽约市原发性 HCV 的风险行为:直肠接收精液、性接触甲基苯丙胺以及使用途径。我们采用安德森-吉尔扩展的考克斯比例危险模型进行了多变量分析:从 2000 年到 2018 年,在 304 名清除了 HCV 的 MSM 艾滋病感染者中,898 人年中有 42 人再次感染,发病率为每 100 人年 4.7 例。对清除后的 1245 次就诊进行评估,只有将精液输入直肠与再感染有关(危险比为 9.7 [95% 置信区间:3.3-28.3],P < .001);使用甲基苯丙胺与再感染无关:近 20 年来的高 HCV 再感染率表明,HCV 的性传播并非低效或不寻常,直接作用抗病毒治疗不足以消除纽约市 MSM 中的 HCV。初发感染和 HCV 再感染率与风险因素之间的反差表明,HCV 在性网络中的流行具有高度异质性,甲基苯丙胺的性使用非但不会促成传播,反而会成为 HCV 流行率最高网络的替代标志。在纽约市,避孕套和治疗都不是预防丙型肝炎病毒的成功策略,因此需要采取新的干预措施来阻止丙型肝炎病毒的性传播。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Infectious Diseases
Clinical Infectious Diseases 医学-传染病学
CiteScore
25.00
自引率
2.50%
发文量
900
审稿时长
3 months
期刊介绍: Clinical Infectious Diseases (CID) is dedicated to publishing original research, reviews, guidelines, and perspectives with the potential to reshape clinical practice, providing clinicians with valuable insights for patient care. CID comprehensively addresses the clinical presentation, diagnosis, treatment, and prevention of a wide spectrum of infectious diseases. The journal places a high priority on the assessment of current and innovative treatments, microbiology, immunology, and policies, ensuring relevance to patient care in its commitment to advancing the field of infectious diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信